High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.8M
$1,798,209
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APGE
M
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
Other
2026-03-04
$94,298
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-04 | $94,298 | M | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-04
$390,825x3
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-04 | $390,825x3 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $140,431x4 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS
• CEO
10b5-1 Sell
2026-02-11
$1,266,953Largex3
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $1,266,953Largex3 | S | Form 4 |